Pazopanib

Sold as Votrient, Europan, Pazopanib cipla, Pazopanib eurolab, Pazotev, Pazitorz

C₂₁H₂₃N₇O₂S437.50 g/mol

5-[[4-[(2,3-Dimethylindazol-6-yl)-methylamino]pyrimidin-2-yl]amino]-2-methylbenzenesulfonamide

Drag to rotate. Structure from PubChem CID 10113978.

Loading Wikipedia summary

Registration

Applicants: 5
Registrations: 10
Schedule source: Consolidated Schedules 06 July 2026

Applicants and registrations

Applicant	Brands	Dosages	Registrations	Schedule	Leaflets
Novartis South Africa (Pty) Ltd	Votrient	200 mg, 400 mg	440348, 440349	S4	None
Eurolab (Pty) Ltd	Europan, Pazopanib eurolab	200 mg, 400 mg	550118, 560345, 560346	S4	PI PIL
Cipla Medpro (Pty) Ltd	Pazopanib cipla	200 mg	560080	S4	PI PIL
Teva Pharmaceuticals (Pty) Ltd	Pazotev	200, 400	570150, 570151	S4	PI PIL
Dr Reddyæs Laboratories (Pty) Ltd	Pazitorz	200 mg, 400 mg	570641, 570642	S4	None

Variants

Product	Strength and form	Registration	Status	Schedule	Leaflets
Votrient 200 MG EACH TABLET CONTAINS PAZOPANIB HYDROCHLORIDE EQUIVALENT TO PAZOPANIB 200,0 mg	200 mg	44034844/26/0348	Registered	S4	None
Votrient 400 MG EACH TABLET CONTAINS PAZOPANIB HYDROCHLORIDE EQUIVALENT TO PAZOPANIB 400,0 mg	400 mg	44034944/26/0349	Registered	S4	None
Europan 200 MG PAZOPANIB HYDROCHLORIDE	200 mgTablet	55011855/26/0118Approved 22 November 2022	Registered	S4	PI PIL
Pazopanib 200 cipla EACH TABLET CONTAINS PAZOPANIB HYDROCHLORIDE 200,0 mg	200 mgTablet	56008056/26/0080Approved 29 August 2023	Registrered	S4	PI PIL
Pazopanib 200 MG eurolab EACH TABLET CONTAINS: PAZOPANIB HYDROCHLORIDE EQUIVALENT TO PAZOPANIB 200,0 mg	200 mgFilm-coated tablet	56034556/26/0345Approved 15 July 2025	Registered	S4	PI PIL
Pazopanib 400 MG eurolab EACH TABLET CONTAINS: PAZOPANIB HYDROCHLORIDE EQUIVALENT TO PAZOPANIB 400,0 mg	400 mg	56034656/26/0346	Registered	S4	None
Pazotev 200 EACH TABLET CONTAINS PAZOPANIB HYDROCHLORIDE EQUIVALENT TO PAZOPANIB 200,0 mg	200Film-coated tablets	57015057/26/0150Approved 18 March 2025	Registered	S4	PI PIL
Pazotev 400 EACH TABLET CONTAINS PAZOPANIB HYDROCHLORIDE EQUIVALENT TO PAZOPANIB 400,0 mg	400Film-coated tablets	57015157/26/0151Approved 18 March 2025	Registered	S4	PI PIL
Pazitorz 200 MG EACH TABLET CONTAINS PAZOPANIB HYDROCHLORIDE 200,0 mg	200 mg	57064157/26/0641	Registered	S4	None
Pazitorz 400 MG EACH TABLET CONTAINS PAZOPANIB HYDROCHLORIDE 200,0 mg	400 mg	57064257/26/0642	Registered	S4	None

Regulatory status

Where S4 sits on the scale

S0S1S2S3S4S5S6S7S8

Prescription-only medicine.

Schedule 4 covers most ordinary prescription medicines. You need a prescription from an authorised prescriber, such as a doctor or dentist, and a pharmacist dispenses it. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.

Schedule S4, matched to the Consolidated Schedules by ingredient, confidence high.

Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.

Consolidated Schedules listings for Pazopanib hydrochloride equivalent to pazopanib

S4: Pazopanib
Consolidated Schedules 06 July 2026, line 7490

Pharmacological class: Cytostatic agents (class 26)

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

SAHPRA documents

Schedule verified from official documents

Schedule Verification

Europan 200 MG, Eurolab (Pty) Ltd is scheduled S4 in its official SAHPRA documents, read with 90% confidence.

Professional information (PI)For healthcare professionalsEuropan 200 MG, Eurolab (Pty) Ltd Patient information leaflet (PIL)For patients and carersEuropan 200 MG, Eurolab (Pty) Ltd

These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.

Research articles

Loading PubMed articles

Background